Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of WHO 2016 update of brain tumor classification, molecular markers and clinical outcomes in pleomorphic xanthoastrocytoma.

Journal of neuro-oncology - 1 Jan 2018

Tonse Raees, Gupta Tejpal, Epari Sridhar, Shastri Jayant Goda, Gurav Mamta, Bano Nazia, Jalali Rakesh

Abstract excerpt

We present outcomes of pleomorphic xanthoastrocytoma (PXA) and correlate the impact of clinical, pathologic and molecular markers. Between 2006 and 2016, 37 patients with histologically verified PXA form the study cohort. All underwent maximal safe resection; those who had good resection and young age were observed. Adjuvant radiotherapy was given in patients with some atypical features such as high MIB-1 index...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain Neoplasms

Share to Kaplan-Meier Estimate

Share to Proto-Oncogene Proteins B-raf

Share to Radiotherapy, Adjuvant

Share to Treatment Outcome

Share to World Health Organization

Source

Identifiers

PMID: 29147864
DOI: 10.1007/s11060-017-2658-7

Genes

IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of WHO 2016 update of brain tumor classification, molecular markers and clinical outcomes in pleomorphic xanthoastrocytoma.PMID 29147864Read ↗

BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma.Semantic proximity Read ↗

Pleomorphic xanthoastrocytoma, anaplastic pleomorphic xanthoastrocytoma, and epithelioid glioblastoma: Case series with clinical characteristics, molecular features and progression relationship.Semantic proximity Read ↗

Pleomorphic Xanthoastrocytoma, Anaplastic Pleomorphic Xanthoastrocytoma, and Epithelioid Glioblastoma: Case Series with Clinical Characteristics, Molecular Features and Progression RelationshipSemantic proximity Read ↗

The evolution of pleomorphic xanthoastrocytoma: from genesis to molecular alterations and mimics.Semantic proximity Read ↗

Molecular Features and Prognostic Factors of Pleomorphic Xanthoastrocytoma: A Collaborative Investigation of the Tohoku Brain Tumor Study Group.Semantic proximity Read ↗

Biology and grading of pleomorphic xanthoastrocytoma—what have we learned about it?Semantic proximity Read ↗

Anaplastic PXA in adults: case series with clinicopathologic and molecular features.Semantic proximity Read ↗

PXA-like tumors: prognostic implications.Semantic proximity Read ↗

Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytomaSemantic proximity Read ↗

Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival.Semantic proximity Read ↗

Clinical, Morphological, and Molecular Study on Grade 2 and 3 Pleomorphic Xanthoastrocytoma.Semantic proximity Read ↗

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.